Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Targeting the Aryl Hydrocarbon Receptor With Indole-3-Aldehyde Protects From Vulvovaginal Candidiasis via the IL-22-IL-18 Cross-Talk.

Borghi M, Pariano M, Solito V, Puccetti M, Bellet MM, Stincardini C, Renga G, Vacca C, Sellitto F, Mosci P, Brancorsini S, Romani L, Costantini C.

Front Immunol. 2019 Oct 11;10:2364. doi: 10.3389/fimmu.2019.02364. eCollection 2019.

2.

Exploring Readiness for Change: Knowledge and Attitudes towards Family Violence among Community Members and Service Providers Engaged in Primary Prevention in Regional Australia.

Puccetti M, Greville H, Robinson M, White D, Papertalk L, Thompson SC.

Int J Environ Res Public Health. 2019 Oct 30;16(21). pii: E4215. doi: 10.3390/ijerph16214215.

3.

Identification of a novel large EPCAM-MSH2 duplication, concurrently with LOHs in chromosome 20 and X, in a family with Lynch syndrome.

Pirini F, Tedaldi G, Danesi R, Cangini I, Tumedei MM, Ferrari A, Vitali S, De Maio G, Terragna C, Solli V, Tebaldi M, Puccetti M, Zampiga V, Ravegnani M, Ulivi P, Falcini F, Martinelli G, Calistri D.

Int J Colorectal Dis. 2019 Nov;34(11):1999-2002. doi: 10.1007/s00384-019-03414-y. Epub 2019 Oct 26.

PMID:
31655866
4.

Explaining the aggressiveness of breast cancer in sub-Saharan African patients.

Bravaccini S, Bucchi L, Puccetti M, Ravaioli S, Tumedei MM, Serra P, Masini C, Kahima J, Masalu N, Amadori D.

J Clin Pathol. 2019 Oct;72(10):723-724. doi: 10.1136/jclinpath-2019-206071. Epub 2019 Aug 13. No abstract available.

PMID:
31409610
5.

IL-33 Is a Cell-Intrinsic Regulator of Fitness during Early B Cell Development.

Stier MT, Mitra R, Nyhoff LE, Goleniewska K, Zhang J, Puccetti MV, Casanova HC, Seegmiller AC, Newcomb DC, Kendall PL, Eischen CM, Peebles RS Jr.

J Immunol. 2019 Sep 15;203(6):1457-1467. doi: 10.4049/jimmunol.1900408. Epub 2019 Aug 7.

PMID:
31391233
6.

A systems genomics approach identifies SIGLEC15 as a susceptibility factor in recurrent vulvovaginal candidiasis.

Jaeger M, Pinelli M, Borghi M, Constantini C, Dindo M, van Emst L, Puccetti M, Pariano M, Ricaño-Ponce I, Büll C, Gresnigt MS, Wang X, Gutierrez Achury J, Jacobs CWM, Xu N, Oosting M, Arts P, Joosten LAB, van de Veerdonk FL, Veltman JA, Ten Oever J, Kullberg BJ, Feng M, Adema GJ, Wijmenga C, Kumar V, Sobel J, Gilissen C, Romani L, Netea MG.

Sci Transl Med. 2019 Jun 12;11(496). pii: eaar3558. doi: 10.1126/scitranslmed.aar3558.

PMID:
31189718
7.

Evaluation of Androgen Receptor in Relation to Estrogen Receptor (AR/ER) and Progesterone Receptor (AR/PgR): A New Must in Breast Cancer?

Bronte G, Rocca A, Ravaioli S, Scarpi E, Bonafè M, Puccetti M, Maltoni R, Andreis D, Martinelli G, Bravaccini S.

J Oncol. 2019 Apr 14;2019:1393505. doi: 10.1155/2019/1393505. eCollection 2019.

8.

MicroRNA-21 is Required for Hematopoietic Cell Viability After Radiation Exposure.

Puccetti MV, Adams CM, Dan TD, Palagani A, Simone BA, DeAngelis T, Eischen CM, Simone NL.

Int J Radiat Oncol Biol Phys. 2019 Aug 1;104(5):1165-1174. doi: 10.1016/j.ijrobp.2019.04.020. Epub 2019 Apr 27.

PMID:
31039423
9.

Preoperative charcoal suspension tattoo for the detection of differentiated thyroid cancer recurrence.

Soprani F, De Vito A, Bondi F, Magliulo G, Rene SS, Cappi C, Riganti F, Vicini C, Puccetti M.

Mol Clin Oncol. 2019 May;10(5):524-530. doi: 10.3892/mco.2019.1826. Epub 2019 Mar 15.

10.

Programmed death ligand 1 expression in early stage, resectable non-small cell lung cancer.

D'Arcangelo M, D'Incecco A, Ligorio C, Damiani S, Puccetti M, Bravaccini S, Terracciano L, Bennati C, Minuti G, Vecchiarelli S, Landi L, Milesi M, Meroni A, Ravaioli S, Tumedei MM, Incarbone M, Cappuzzo F.

Oncotarget. 2019 Jan 15;10(5):561-572. doi: 10.18632/oncotarget.26529. eCollection 2019 Jan 15.

11.

Smarcal1 and Zranb3 Protect Replication Forks from Myc-Induced DNA Replication Stress.

Puccetti MV, Adams CM, Kushinsky S, Eischen CM.

Cancer Res. 2019 Apr 1;79(7):1612-1623. doi: 10.1158/0008-5472.CAN-18-2705. Epub 2019 Jan 4.

PMID:
30610086
12.

Epithelial-to-mesenchymal transition and EGFR status in NSCLC: the role of vimentin expression.

Bronte G, Puccetti M, Crinò L, Bravaccini S.

Ann Oncol. 2019 Feb 1;30(2):339-340. doi: 10.1093/annonc/mdy548. No abstract available.

PMID:
30576405
13.

The Mast Cell-Aryl Hydrocarbon Receptor Interplay at the Host-Microbe Interface.

Costantini C, Renga G, Oikonomou V, Paolicelli G, Borghi M, Pariano M, De Luca A, Puccetti M, Stincardini C, Mosci P, Bartoli A, Zelante T, Romani L.

Mediators Inflamm. 2018 Oct 28;2018:7396136. doi: 10.1155/2018/7396136. eCollection 2018. Review.

14.

Frequency of actionable alterations in epidermal growth factor receptor (EGFR) wild type non-small cell lung cancer: experience of the Wide Catchment Area of Romagna (AVR).

Chiadini E, Canale M, Delmonte A, Dazzi C, Casanova C, Capelli L, Mariotti M, Papi M, Gamboni A, Puccetti M, Bravaccini S, Dubini A, Calistri D, Crinò L, Ulivi P.

J Thorac Dis. 2018 Aug;10(8):4858-4864. doi: 10.21037/jtd.2018.07.22.

15.

Are fine-needle aspiration biopsy-derived cell blocks a useful surrogate for tissue samples in breast cancer?

Puccetti M, Ravaioli S, Tumedei MM, Bucchi E, Malmesi M, Medri L, Bravaccini S.

Histopathology. 2018 Nov;73(5):801-808. doi: 10.1111/his.13694. Epub 2018 Aug 27.

PMID:
29944734
16.

Androgen Receptor Expression in Breast Cancer: What Differences Between Primary Tumor and Metastases?

Bronte G, Bravaccini S, Ravaioli S, Puccetti M, Scarpi E, Andreis D, Tumedei MM, Sarti S, Cecconetto L, Pietri E, De Simone V, Maltoni R, Bonafè M, Amadori D, Rocca A.

Transl Oncol. 2018 Aug;11(4):950-956. doi: 10.1016/j.tranon.2018.05.006. Epub 2018 Jun 18.

17.

Development of Novel Indole-3-Aldehyde-Loaded Gastro-Resistant Spray-Dried Microparticles for Postbiotic Small Intestine Local Delivery.

Puccetti M, Giovagnoli S, Zelante T, Romani L, Ricci M.

J Pharm Sci. 2018 Sep;107(9):2341-2353. doi: 10.1016/j.xphs.2018.04.023. Epub 2018 Apr 30.

PMID:
29715478
18.

Autophagy and LAP in the Fight against Fungal Infections: Regulation and Therapeutics.

Oikonomou V, Renga G, De Luca A, Borghi M, Pariano M, Puccetti M, Paolicelli G, Stincardini C, Costantini C, Bartoli A, Zelante T, Romani L.

Mediators Inflamm. 2018 Mar 6;2018:6195958. doi: 10.1155/2018/6195958. eCollection 2018. Review.

19.

Towards Targeting the Aryl Hydrocarbon Receptor in Cystic Fibrosis.

Puccetti M, Paolicelli G, Oikonomou V, De Luca A, Renga G, Borghi M, Pariano M, Stincardini C, Scaringi L, Giovagnoli S, Ricci M, Romani L, Zelante T.

Mediators Inflamm. 2018 Feb 18;2018:1601486. doi: 10.1155/2018/1601486. eCollection 2018. Review.

20.

Are There Differences in Androgen Receptor Expression in Invasive Breast Cancer in African (Tanzanian) Population in Comparison With the Caucasian (Italian) Population?

Bravaccini S, Ravaioli S, Amadori D, Scarpi E, Puccetti M, Rocca A, Tumedei MM, Masalu N, Kahima J, Pangan A, Faustine L, Farolfi A, Maltoni R, Bonafè M, Serra P, Bronte G.

Front Endocrinol (Lausanne). 2018 Mar 29;9:137. doi: 10.3389/fendo.2018.00137. eCollection 2018.

21.

Androgen receptor in advanced breast cancer: is it useful to predict the efficacy of anti-estrogen therapy?

Bronte G, Rocca A, Ravaioli S, Puccetti M, Tumedei MM, Scarpi E, Andreis D, Maltoni R, Sarti S, Cecconetto L, Fedeli A, Pietri E, De Simone V, Asioli S, Amadori D, Bravaccini S.

BMC Cancer. 2018 Mar 27;18(1):348. doi: 10.1186/s12885-018-4239-3.

22.

Deficiency of immunoregulatory indoleamine 2,3-dioxygenase 1in juvenile diabetes.

Orabona C, Mondanelli G, Pallotta MT, Carvalho A, Albini E, Fallarino F, Vacca C, Volpi C, Belladonna ML, Berioli MG, Ceccarini G, Esposito SM, Scattoni R, Verrotti A, Ferretti A, De Giorgi G, Toni S, Cappa M, Matteoli MC, Bianchi R, Matino D, Iacono A, Puccetti M, Cunha C, Bicciato S, Antognelli C, Talesa VN, Chatenoud L, Fuchs D, Pilotte L, Van den Eynde B, Lemos MC, Romani L, Puccetti P, Grohmann U.

JCI Insight. 2018 Mar 22;3(6). pii: 96244. doi: 10.1172/jci.insight.96244.

23.

PSMA expression: a potential ally for the pathologist in prostate cancer diagnosis.

Bravaccini S, Puccetti M, Bocchini M, Ravaioli S, Celli M, Scarpi E, De Giorgi U, Tumedei MM, Raulli G, Cardinale L, Paganelli G.

Sci Rep. 2018 Mar 9;8(1):4254. doi: 10.1038/s41598-018-22594-1.

24.

Are Androgen and Estrogen Receptors in DCIS Patients Prognostic Indicators of Relapse Independently of Treatment?

Ravaioli S, Puccetti M, Tumedei MM, Silvestrini R, Bedei L, Bravaccini S.

Appl Immunohistochem Mol Morphol. 2019 Apr;27(4):301-305. doi: 10.1097/PAI.0000000000000582.

PMID:
28968271
25.

Setting up a community-based cervical screening service in a low-income country: a pilot study from north-western Tanzania.

Masalu N, Serra P, Amadori D, Kahima J, Majinge C, Rwehabura J, Nanni O, Bravaccini S, Puccetti M, Tumino R, Bucchi L.

Int J Public Health. 2017 Sep;62(7):755-762. doi: 10.1007/s00038-017-0971-8. Epub 2017 Apr 19.

26.

A mast cell-ILC2-Th9 pathway promotes lung inflammation in cystic fibrosis.

Moretti S, Renga G, Oikonomou V, Galosi C, Pariano M, Iannitti RG, Borghi M, Puccetti M, De Zuani M, Pucillo CE, Paolicelli G, Zelante T, Renauld JC, Bereshchenko O, Sportoletti P, Lucidi V, Russo MC, Colombo C, Fiscarelli E, Lass-Flörl C, Majo F, Ricciotti G, Ellemunter H, Ratclif L, Talesa VN, Napolioni V, Romani L.

Nat Commun. 2017 Jan 16;8:14017. doi: 10.1038/ncomms14017.

27.

Noncanonical Fungal Autophagy Inhibits Inflammation in Response to IFN-γ via DAPK1.

Oikonomou V, Moretti S, Renga G, Galosi C, Borghi M, Pariano M, Puccetti M, Palmerini CA, Amico L, Carotti A, Prezioso L, Spolzino A, Finocchi A, Rossi P, Velardi A, Aversa F, Napolioni V, Romani L.

Cell Host Microbe. 2016 Dec 14;20(6):744-757. doi: 10.1016/j.chom.2016.10.012. Epub 2016 Nov 23.

28.

No evidence of NRAS mutation in squamous cell anal carcinoma (SCAC).

Capelli L, Casadei Gardini A, Scarpi E, Frassineti GL, Saragoni L, Puccetti M, Scartozzi M, Giannini M, Tamberi S, Corbelli J, Ulivi P.

Sci Rep. 2016 Nov 25;6:37621. doi: 10.1038/srep37621.

29.

Easily detectable cytomorphological features to evaluate during ROSE for rapid lung cancer diagnosis: from cytology to histology.

Ravaioli S, Bravaccini S, Tumedei MM, Pironi F, Candoli P, Puccetti M.

Oncotarget. 2017 Feb 14;8(7):11199-11205. doi: 10.18632/oncotarget.13204.

30.

Defective replication stress response inhibits lymphomagenesis and impairs lymphocyte reconstitution.

Puccetti MV, Fischer MA, Arrate MP, Boyd KL, Duszynski RJ, Bétous R, Cortez D, Eischen CM.

Oncogene. 2017 May 4;36(18):2553-2564. doi: 10.1038/onc.2016.408. Epub 2016 Oct 31.

31.

Role of Telomerase in Cervical Lesions as Prognostic Marker: A Comparison Between Immunohistochemistry and Fluorescence In Situ Hybridization.

Ravaioli S, Tumedei MM, Amadori A, Puccetti M, Chiadini E, Bravaccini S.

J Low Genit Tract Dis. 2017 Jan;21(1):42-46. doi: 10.1097/LGT.0000000000000261.

PMID:
27611439
32.

miR-17-92a-1 cluster host gene (MIR17HG) evaluation and response to neoadjuvant chemoradiotherapy in rectal cancer.

Molinari C, Salvi S, Foca F, Teodorani N, Saragoni L, Puccetti M, Passardi A, Tamberi S, Avanzolini A, Lucci E, Calistri D.

Onco Targets Ther. 2016 May 6;9:2735-42. doi: 10.2147/OTT.S105760. eCollection 2016.

33.

IL-1 receptor antagonist ameliorates inflammasome-dependent inflammation in murine and human cystic fibrosis.

Iannitti RG, Napolioni V, Oikonomou V, De Luca A, Galosi C, Pariano M, Massi-Benedetti C, Borghi M, Puccetti M, Lucidi V, Colombo C, Fiscarelli E, Lass-Flörl C, Majo F, Cariani L, Russo M, Porcaro L, Ricciotti G, Ellemunter H, Ratclif L, De Benedictis FM, Talesa VN, Dinarello CA, van de Veerdonk FL, Romani L.

Nat Commun. 2016 Mar 14;7:10791. doi: 10.1038/ncomms10791.

34.

Association of a variable number tandem repeat in the NLRP3 gene in women with susceptibility to RVVC.

Jaeger M, Carvalho A, Cunha C, Plantinga TS, van de Veerdonk F, Puccetti M, Galosi C, Joosten LA, Dupont B, Kullberg BJ, Sobel JD, Romani L, Netea MG.

Eur J Clin Microbiol Infect Dis. 2016 May;35(5):797-801. doi: 10.1007/s10096-016-2600-5. Epub 2016 Mar 7.

35.

Nonsquamous, Non-Small-Cell Lung Cancer Patients Who Carry a Double Mutation of EGFR, EML4-ALK or KRAS: Frequency, Clinical-Pathological Characteristics, and Response to Therapy.

Ulivi P, Chiadini E, Dazzi C, Dubini A, Costantini M, Medri L, Puccetti M, Capelli L, Calistri D, Verlicchi A, Gamboni A, Papi M, Mariotti M, De Luigi N, Scarpi E, Bravaccini S, Turolla GM, Amadori D, Crinò L, Delmonte A.

Clin Lung Cancer. 2016 Sep;17(5):384-390. doi: 10.1016/j.cllc.2015.11.004. Epub 2015 Dec 1.

PMID:
26712101
36.

Pathogenic NLRP3 Inflammasome Activity during Candida Infection Is Negatively Regulated by IL-22 via Activation of NLRC4 and IL-1Ra.

Borghi M, De Luca A, Puccetti M, Jaeger M, Mencacci A, Oikonomou V, Pariano M, Garlanda C, Moretti S, Bartoli A, Sobel J, van de Veerdonk FL, Dinarello CA, Netea MG, Romani L.

Cell Host Microbe. 2015 Aug 12;18(2):198-209. doi: 10.1016/j.chom.2015.07.004.

37.

Role of androgen and estrogen receptors as prognostic and potential predictive markers of ductal carcinoma in situ of the breast.

Tumedei MM, Silvestrini R, Ravaioli S, Massa I, Maltoni R, Rocca A, Folli S, Buggi F, Curcio A, Serra L, Puccetti M, Amadori D, Bravaccini S.

Int J Biol Markers. 2015 Nov 11;30(4):e425-8. doi: 10.5301/jbm.5000163.

PMID:
26165687
38.

Fine-tuning of Th17 Cytokines in Periodontal Disease by IL-10.

Moretti S, Bartolommei L, Galosi C, Renga G, Oikonomou V, Zamparini F, Ricci G, Borghi M, Puccetti M, Piobbico D, Eramo S, Conti C, Lomurno G, Bartoli A, Napolioni V, Romani L.

J Dent Res. 2015 Sep;94(9):1267-75. doi: 10.1177/0022034515591790. Epub 2015 Jun 19.

PMID:
26092379
39.

ALK translocation detection in non-small cell lung cancer cytological samples obtained by TBNA or EBUS-TBNA.

Bravaccini S, Tumedei MM, Ulivi P, Zoli W, Calistri D, Candoli P, Amadori D, Puccetti M.

Cytopathology. 2016 Apr;27(2):103-7. doi: 10.1111/cyt.12237. Epub 2015 Mar 10.

PMID:
25757141
40.

Gene mutation analysis in EGFR wild type NSCLC responsive to erlotinib: are there features to guide patient selection?

Ulivi P, Delmonte A, Chiadini E, Calistri D, Papi M, Mariotti M, Verlicchi A, Ragazzini A, Capelli L, Gamboni A, Puccetti M, Dubini A, Burgio MA, Casanova C, Crinò L, Amadori D, Dazzi C.

Int J Mol Sci. 2014 Dec 31;16(1):747-57. doi: 10.3390/ijms16010747.

41.

IL-37 inhibits inflammasome activation and disease severity in murine aspergillosis.

Moretti S, Bozza S, Oikonomou V, Renga G, Casagrande A, Iannitti RG, Puccetti M, Garlanda C, Kim S, Li S, van de Veerdonk FL, Dinarello CA, Romani L.

PLoS Pathog. 2014 Nov 6;10(11):e1004462. doi: 10.1371/journal.ppat.1004462. eCollection 2014 Nov.

42.

Antifungal Th Immunity: Growing up in Family.

Borghi M, Renga G, Puccetti M, Oikonomou V, Palmieri M, Galosi C, Bartoli A, Romani L.

Front Immunol. 2014 Oct 15;5:506. doi: 10.3389/fimmu.2014.00506. eCollection 2014. Review.

43.

New biomarkers to predict the evolution of in situ breast cancers.

Bravaccini S, Tumedei MM, Scarpi E, Zoli W, Rengucci C, Serra L, Curcio A, Buggi F, Folli S, Rocca A, Maltoni R, Puccetti M, Amadori D, Silvestrini R.

Biomed Res Int. 2014;2014:159765. doi: 10.1155/2014/159765. Epub 2014 Aug 26.

44.

Role of BRAF molecular analysis in the management of papillary thyroid carcinoma: analysis of cytological and histological samples.

Capelli L, Marfisi C, Puccetti M, Saragoni L, De Paola F, Zaccaroni A, Chiadini E, Gagliardi L, Ferretti G, Zoli W, Ulivi P.

Cytopathology. 2015 Oct;26(5):297-302. doi: 10.1111/cyt.12199. Epub 2014 Aug 14.

PMID:
25123949
45.

Promoter methylation of tumor suppressor genes in pre-neoplastic lesions; potential marker of disease recurrence.

Rengucci C, De Maio G, Casadei Gardini A, Zucca M, Scarpi E, Zingaretti C, Foschi G, Tumedei MM, Molinari C, Saragoni L, Puccetti M, Amadori D, Zoli W, Calistri D.

J Exp Clin Cancer Res. 2014 Aug 5;33:65. doi: 10.1186/s13046-014-0065-x.

46.

Differences in biological features of breast cancer between Caucasian (Italian) and African (Tanzanian) populations.

Amadori D, Serra P, Bravaccini S, Farolfi A, Puccetti M, Carretta E, Medri L, Nanni O, Tumedei MM, Kahima J, Masalu N.

Breast Cancer Res Treat. 2014 May;145(1):177-83.

PMID:
24658893
47.

Benefit from anthracyclines in relation to biological profiles in early breast cancer.

Rocca A, Bravaccini S, Scarpi E, Mangia A, Petroni S, Puccetti M, Medri L, Serra L, Ricci M, Cerasoli S, Biglia N, Maltoni R, Giunchi DC, Gianni L, Tienghi A, Brandi M, Faedi M, Sismondi P, Paradiso A, Silvestrini R, Amadori D.

Breast Cancer Res Treat. 2014 Apr;144(2):307-18. doi: 10.1007/s10549-013-2819-0. Epub 2014 Jan 1. Erratum in: Breast Cancer Res Treat. 2014 Apr;144(2):319. Faedi, Monica [corrected to Faedi, Marina].

PMID:
24381054
48.

Molecular determinations of EGFR and EML4-ALK on a single slide of NSCLC tissue.

Ulivi P, Puccetti M, Capelli L, Chiadini E, Bravaccini S, Calistri D, Zoli W, Amadori D, Candoli P.

J Clin Pathol. 2013 Aug;66(8):708-10. doi: 10.1136/jclinpath-2013-201502. Epub 2013 Mar 26.

PMID:
23533259
49.

Charcoal tattoo localization for differentiated thyroid cancer recurrence in the central compartment of the neck.

Soprani F, Bondi F, Puccetti M, Armaroli V.

Acta Otorhinolaryngol Ital. 2012 Apr;32(2):87-92.

50.

EGFR and K-ras mutations in cytologic samples from fine-needle aspirates in NSCLC patients.

Ulivi P, Zoli W, Chiadini E, Capelli L, Candoli P, Calistri D, Silvestrini R, Puccetti M.

Eur Respir J. 2012 Jul;40(1):267-9. doi: 10.1183/09031936.00204511. No abstract available.

Supplemental Content

Loading ...
Support Center